Dr. Madhav Danthala
MBBS, MD, DM (Medical Oncology)
Fellowship in Leukemia and Bone Marrow Transplantation
Medical Oncologist
Dr. Madhav Danthala Appointment and Practice Location
Rajbhavan Road, Matha Nagar,
Somajiguda, Hyderabad
Get Directions
OP Timings
Mon - Sat
Fee: 850
For Appointment
About Dr. Madhav Danthala Medical Oncologist
Dr Madhava Danthala is a consultant medical oncologist based in Hyderabad city. He is currently associated with Yashoda Hospital in Somajiguda. He obtained his degree in MBBS from PES Institute of Medical Sciences and Research, Kippam in 2010, MD in General Medicine from Sri Devaraj Urs Medical College, Kolar in 2013, DM in Medical Oncology from Nizam's Institute of Medical Sciences in 2017. He further completed a certificate course in Operational Research from SOR IT in 2019 and a fellowship in Leukaemia and bone marrow transplantation from Vancouver General Hospital, Canada in 2020. So far, Dr Madhava Danthala has published more than 10 research papers and posters. For his contribution through research in his field of expertise, he received awards such as the Best Poster Presentation Award at ICON in 2016 ant the ISMPO Torrent Young Scholar Award in 2017.
Dr Madhava Danthala has around 12 years of clinical experience in the field of medical oncology. In these 12 years of experience, he gained specialization as Leukaemia and bone marrow transplant. He did his residency in medical oncology at HCG Cancer Center in Bangalore and later worked as a consultant haemato-oncologist and BMT Physician at Manipal Hospitals in Vijayawada. He provides expert services on treating conditions like Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Autologous and Allogeneic Stem Cell Transplant, Blood Disorders, Cancer Nutrition, Childhood Cancers, Chronic Lymphocytic Leukaemia, Chronic Myeloid Leukaemia etc., He also provides therapies like Chemotherapy, Immunotherapy, Targeted therapy and many such therapies which help in terminally ill patients. He is an active member of American Society of Clinical Oncology [ASCO] and European Society of Medical Oncology [ESMO]
Dr Madhava Danthala is currently practicing as a consultant haemato-oncologist and bone marrow transplant physician at Yashoda Hospitals in Somajiguda. He provides expert consultation all week long on an appointment basis.
You can book an appointment on prior basis at the Skedoc.com website.
Practice Locations (1)
Profile
Patient Reviews (2)
Q&A
Specializations
Bonemarrow Transplant
Haemato Oncologist
Expertises
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Anemia
- Autologous and Allogeneic Stem Cell Transplant
- Blood Disorders
- Cancer Nutrition
- Chemotherapy
- Childhood Cancers
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- View More Expertises
Qualifications
- MBBS - PES Institute of Medical Sciences and Research - 2010 - Kuppam
- MD - General Medicine - Sri Devaraj Urs Medical College - 2013 - Kolar
- DM - Medical Oncology - Nizam’s Institute of Medical Sciences - 2017 - Hyderabad
- Certificate Course in Operational Research - SORT IT - 2019
- Fellowship in Leukemia and Bone Marrow Transplantation - Vancouver General Hospital - 2020 - Canada
Experiences
- Resident - Medical Oncology HCG Cancer Center - Bangalore - Jun 2013 - Nov 2013
- Consultant Hemato Oncologist and BMT Physician Manipal Hospitals - Vijayawada - Sep 2017 - Jan 2022
- Consultant Hemato Oncologist and Bone Marrow Transplant Physician Yashoda Hospitals - Somajiguda - Feb 2022 - Currently Working
- 66157 Telangana State Medical Council 2010
- 101618 Karnataka Medical Council 2013
- University Topper Internal Medicine - 2013
- Best Poster Presentation Award at ICON - 2016
- ISMPO Torrent Young Scholar Award - 2017
- 1st Rank in DM Medical Oncology Entrance Examination, Nizam’s Institute of Medical Sciences
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE Therapy in Patients with Neuroendocrine Tumours: 5 Years Experience from a Tertiary Cancer Care Centre in India. European Journal of Nuclear Medicine and Molecular Imaging. 2014 Jul;41(7):1319-26
- Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62
- Danthala M, Golamari KR, Seshachalam A, Mikkilineni A, Chappidi S, Mekala MB, Elangovan V, Chinnakali P. Walking a Tightrope: Dosage Modifications and Treatment Outcomes of All Trans-Retinoic Acid, Arsenic Trioxide, and Daunorubicin for HighRisk Acute Promyelocytic Leukemia. JCO Global Oncology. 2020 Nov;6:1749-56
- Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: 8 Years Experience from a Tertiary Care Center in India. South Asian Journal of Cancer. 2016 Oct;5(04):176-8
- Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study from South India. Clinical Lymphoma Myeloma and Leukemia. 2020 May 1;20(5):e205-11
- Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma Real-World Evidence. Journal of Global Oncology. 2019 Dec;5:1-3
- Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long Term Survival and Late Side Effects of Paediatric Hodgkin Lymphoma Patients: A Study from a Tertiary Care Centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89
- Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910
- Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and Breast Cancer: Association of Serum Adiponectin, Leptin, and Adiponectin–Leptin Ratio as Risk Biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul;39(03):292-6
- Danthala M, Lakshmaiah V. Correlative Study of Serum Cystatin C Levels with Severity of Acute Ischemic Stroke. J Clin Biomed Sci. 2013;3(4):188-92
- Naveen L, Santoshi M, Madhav D, Sri Rama AG, Mahesh V. A Study of the Association of Insulin Resistance and Cardiometabolic Risk Factors in an Adult Population with Type 2 Diabetes Mellitus, Inter. J. Appl. Med. Sci. 2014;4:168-72
- Proffered Paper: Additional Chromosomal Abnormalities in Chronic Myeloid Leukemia: Lest We Forget. Presented at ESMO (European Society of Medical Oncology) Asia 2016, Singapore
Report an error
Dr. Madhav Danthala Reviews
Sort by treatment
Sort by Patient Experience
Hyderabad
22 Aug, 2024|7 months ago
Visited for: Infection in blood
Dr. Madhav Danthala exemplifies not only outstanding expertise as an oncologist but also remarkable compassion as an individual. His dedication to his patients extends well beyond the confines of the clinic, as he fervently champions their health and strives to provide them with the highest standard of care. 939414XXXXHyderabad
04 May, 2024|11 months ago
Visited for: Health issue
He is an excellent doctor. He possesses a sincere and friendly demeanor, attentively listens to concerns, and provides clear advice. 812108XXXX
No Question & Answers by this doctor.
